Stay updated on Pembrolizumab and CC-486 in Platinum-resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and CC-486 in Platinum-resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and CC-486 in Platinum-resistant Ovarian Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now displays a new revision tag 'Revision: v3.5.4', replacing the previous 'Revision: v3.5.3'. This reflects a minor version update to the page rather than any substantive changes to the study details.
    Difference
    0.1%
    Check dated 2026-05-17T09:34:37.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page’s displayed revision/version marker was incremented from v3.5.2 to v3.5.3, reflecting a site release/update rather than a change to the study information.
    Difference
    0.1%
    Check dated 2026-04-25T18:53:49.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T13:44:24.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Footer and policy updates were added, including release notes, privacy and accessibility information, and government links.
    Difference
    100%
    Check dated 2026-03-28T03:46:30.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Footer/navigation items and several archived study documents were removed. The essential trial data remains accessible on the page.
    Difference
    22%
    Check dated 2026-03-21T01:17:26.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3. No substantive content changes are visible.
    Difference
    0.1%
    Check dated 2026-03-06T17:49:35.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and CC-486 in Platinum-resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and CC-486 in Platinum-resistant Ovarian Cancer Clinical Trial page.